DEVICES, SYSTEMS AND METHODS FOR TREATMENT OF NEUROPSYCHIATRIC DISORDERS

• US 20130158626A1
• Filed: 02/15/2013
• Published: 06/20/2013
• Est. Priority Date: 10/05/2009
• Status: Active Grant

• Current Assignee: Regents of the University of California (University of California)
• Original Assignee: Regents of the University of California (University of California)
• Inventors: DeGIORGIO, Christopher, Cook, Ian A., Covalin, Alejandro, Miller, Patrick R., Schrader, Lara
• Granted Patent: US 8,700,164 B2
• Time in Patent Office: Days
• US Class Current: 607/45
• CPC Class Codes: A61N 1/0456 Specially adapted for transcutaneous electrical nerve stimulation [TENS]
• CPC Class Codes: A61N 1/0476 Array electrodes (including any electrode arrangement with more than one electrode for at least one of the polarities)
• CPC Class Codes: A61N 1/0492 Patch electrodes A61N1/0412, A61N1/0428 take precedence
• CPC Class Codes: A61N 1/0504 Subcutaneous electrodes
• CPC Class Codes: A61N 1/0529 Electrodes for brain stimulation
• CPC Class Codes: A61N 1/0551 Spinal or peripheral nerve electrodes
• CPC Class Codes: A61N 1/36021 for treatment of pain
• CPC Class Codes: A61N 1/36025 for treating a mental or cerebral condition
• CPC Class Codes: A61N 1/36064 Epilepsy
• CPC Class Codes: A61N 1/36067 Movement disorders, e.g. tremor or Parkinson disease stimulating motor muscle A61N1/36003
• CPC Class Codes: A61N 1/36075 Headache or migraine
• CPC Class Codes: A61N 1/36082 Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease
• CPC Class Codes: A61N 1/36096 Mood disorders, e.g. depression, anxiety or panic disorder
• CPC Class Codes: A61N 1/3616 Voltage density or current density
• CPC Class Codes: A61N 1/36171 Frequency
• CPC Class Codes: A61N 1/36175 Pulse width or duty cycle

Abstract

The present disclosure relates to methods, devices and systems used for the treatment of mood, anxiety, post traumatic stress disorder, and cognitive and behavioral disorders (collectively, neuropsychiatric disorders) via stimulation of the superficial elements of the trigeminal nerve (“TNS”). More specifically, cutaneous methods of stimulation of the superficial branches of the trigeminal nerve located extracranially in the face, namely the supraorbital, supratrochlear, infraorbital, auriculotemporal, zygomaticotemporal, zygomaticoorbital, zygomaticofacial, infraorbital, nasal and mentalis nerves (also referred to collectively as the superficial trigeminal nerve) are disclosed herein.

Claims

1. A system for trigeminal nerve stimulation for treatment of a neuropsychiatric disorder, the system comprising:

a pulse generator; and

a cutaneous electrode assembly in electrical communication with the pulse generator, the assembly comprising;

a first electrode comprising at least one contact configured for cutaneous placement directly over or adjacent an ophthalmic nerve on one side of a patient'"'"'s forehead, and

a second electrode comprising at least one contact configured for cutaneous placement directly over or adjacent a remaining ophthalmic nerve on an opposing side of the patient'"'"'s forehead.

2. The system of claim 1, further comprising a wire operably connecting the pulse generator and the cutaneous electrode assembly.

3. The system of claim 1, further comprising a regulating device configured to regulate a maximum charge balanced output current through the first and second electrodes below approximately 30-50 mA.

4. The system of claim 1, wherein the neuropsychiatric disorder is selected from the group consisting of:

mood disorder, cognitive disorder, behavioral disorder and anxiety disorder.

5. The system of claim 1, wherein the pulse generator is configured to apply electrical signals at a frequency between approximately 20 and 300 Hertz, at a pulse duration between approximately 50 and 500 microseconds, at an output current density of not greater than approximately 25 mA/cm² and an output charge density of not greater than approximately 10 microCoulomb/cm² at the cerebral cortex.

6. A system for trigeminal nerve stimulation for treatment of a neuropsychiatric disorder, the system comprising:

a pulse generator; and

a cutaneous electrode assembly in electrical communication with the pulse generator, the assembly comprising;

a first electrode contact configured for cutaneous placement directly over or adjacent a trigeminal nerve branch on a patient, and

a second electrode contact configured for cutaneous placement directly over or adjacent the trigeminal nerve branch on the patient, wherein the trigeminal nerve branch is selected from the group consisting of the mandibular nerve and the maxillary nerve.

7. The system of claim 6, further comprising a wire operably connecting the pulse generator and the cutaneous electrode assembly.

8. The system of claim 6, further comprising a regulating device configured to regulate a maximum charge balanced output current through the first and second electrode contacts below approximately 30-50 mA.

9. The system of claim 6, wherein the neuropsychiatric disorder is selected from the group consisting of:

mood disorder, cognitive disorder, behavioral disorder and anxiety disorder.

10. The system of claim 6, wherein the pulse generator is configured to apply electrical signals at a frequency between approximately 20 and 300 Hertz, at a pulse duration between approximately 50 and 500 microseconds, at an output current density of not greater than approximately 25 mA/cm² and an output charge density of not greater than approximately 10 microCoulomb/cm² at the cerebral cortex.

11. A method for treating a neuropsychiatric disorder by trigeminal nerve stimulation, comprising:

applying a first electrode contact for a cutaneous electrode assembly directly over or adjacent to an ophthalmic nerve on one side of the patient'"'"'s forehead;

applying a second electrode contact for the cutaneous electrode assembly directly over or adjacent to a remaining ophthalmic nerve on an opposing side of the patient'"'"'s forehead; and

driving electrical signals through the first and second electrode contacts at specified operational parameters to treat the neuropsychiatric disorder.

12. The method of claim 11, wherein the step of driving the electrical signals comprises driving the electrical signals at a frequency between approximately 20 and 300 Hertz, at a current of 0.05 to 5 milliamperes (mA) and at a pulse duration of less than or equal to 500 microseconds.

13. The method of claim 11, wherein the step of driving the electrical signals results in an output current density of not greater than approximately 25 mA/cm² and a charge density of not greater than approximately 10 microCoulomb/cm² at the cerebral cortex of the patient.

14. The method of claim 14, wherein the neuropsychiatric disorder is selected from the group consisting of:

mood disorder, cognitive disorder, behavioral disorder and anxiety disorder.

15. A method for treating a neuropsychiatric disorder by trigeminal nerve stimulation, comprising:

applying a cutaneous electrode assembly directly over or adjacent to a trigeminal nerve branch on a patient; and

driving electrical signals through electrode contacts in the cutaneous electrode assembly at specified operational parameters to treat the neuropsychiatric disorder, wherein the trigeminal nerve branch is selected from the group consisting of the mandibular nerve and the maxillary nerve.

16. The method of claim 15, wherein the step of driving the electrical signals comprises driving the electrical signals at a frequency between approximately 20 and 300 Hertz, at a current of 0.05 to 5 milliamperes (mA) and at a pulse duration of less than or equal to 500 microseconds.

17. The method of claim 15, wherein the step of driving the electrical signals results in an output current density of not greater than approximately 25 mA/cm² and a charge density of not greater than approximately 10 microCoulomb/cm² at the cerebral cortex of the patient.

18. The method of claim 15, wherein the neuropsychiatric disorder is selected from the group consisting of:

mood disorder, cognitive disorder, behavioral disorder and anxiety disorder.